Bioharvest Sciences Inc (BHST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 04-2019 | 12-2018 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -6,584 | -5,310 | -5,135 | N/A |
| Depreciation Amortization | 288 | 324 | N/A | N/A |
| Accounts receivable | -73 | -36 | N/A | N/A |
| Other Working Capital | -232 | 674 | -450 | N/A |
| Other Operating Activity | 2,726 | 1,965 | 3,897 | 0 |
| Operating Cash Flow | $-3,875 | $-2,383 | $-1,688 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -173 | -34 | N/A | N/A |
| Investing Cash Flow | $-173 | $-34 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 769 | 1,731 | N/A | N/A |
| Debt Repayment | N/A | -71 | N/A | N/A |
| Common Stock Issued | 4,469 | 742 | N/A | N/A |
| Other Financing Activity | -312 | -280 | 2,227 | 0 |
| Financing Cash Flow | $4,926 | $2,122 | $2,227 | $N/A |
| Exchange Rate Effect | -6 | 7 | -7 | N/A |
| Beginning Cash Position | 911 | 1,199 | 0 | N/A |
| End Cash Position | 1,783 | 911 | 532 | N/A |
| Net Cash Flow | $872 | $-288 | $532 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -3,875 | -2,383 | -1,688 | N/A |
| Capital Expenditure | -173 | -34 | N/A | N/A |
| Free Cash Flow | -4,048 | -2,417 | -1,688 | 0 |